Emmi Sarvikivi

1.0k total citations
19 papers, 477 citations indexed

About

Emmi Sarvikivi is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Emmi Sarvikivi has authored 19 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Epidemiology. Recurrent topics in Emmi Sarvikivi's work include Neonatal and Maternal Infections (5 papers), COVID-19 epidemiological studies (4 papers) and Nosocomial Infections in ICU (4 papers). Emmi Sarvikivi is often cited by papers focused on Neonatal and Maternal Infections (5 papers), COVID-19 epidemiological studies (4 papers) and Nosocomial Infections in ICU (4 papers). Emmi Sarvikivi collaborates with scholars based in Finland, Sweden and United States. Emmi Sarvikivi's co-authors include Harri Saxén, Maija Lappalainen, Outi Lyytikäinen, Päivi Luukkainen, Outi Lyytikäinen, Claude Pujol, Malcolm Richardson, Pirkko Koukila-Kähkölä, Michael A. Pfaller and David R. Soll and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy and BMC Public Health.

In The Last Decade

Emmi Sarvikivi

19 papers receiving 455 citations

Peers

Countries citing papers authored by Emmi Sarvikivi

Since Specialization

Citations

This map shows the geographic impact of Emmi Sarvikivi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmi Sarvikivi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmi Sarvikivi more than expected).

Fields of papers citing papers by Emmi Sarvikivi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmi Sarvikivi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmi Sarvikivi. The network helps show where Emmi Sarvikivi may publish in the future.

Co-authorship network of co-authors of Emmi Sarvikivi

This figure shows the co-authorship network connecting the top 25 collaborators of Emmi Sarvikivi. A scholar is included among the top collaborators of Emmi Sarvikivi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmi Sarvikivi. Emmi Sarvikivi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Decline in varicella cases contacting primary health care after introduction of varicella vaccination in Finland – A population-based register study 2023 ·Vaccine ·Heini Salo, Jori Perälä, Tuula Hannila‐Handelberg, Emmi Sarvikivi, Oskari Luomala, Jukka Ollgren, Tuija Leino	5
2	When schools were open for in-person teaching during the COVID-19 pandemic - the nordic experience on control measures and transmission in schools during the delta wave 2023 ·BMC Public Health ·(unknown), Karin Nygård, Laura Espenhain, Rebecca Legarth, Karina Lauenborg Møller, Emmi Sarvikivi, Otto Helve, Guðrún Aspelund, (unknown), (unknown), Margrethe Greve‐Isdahl, (unknown), Tone Bjordal Johansen	3
3	Face mask recommendations in schools did not impact COVID-19 incidence among 10–12-year-olds in Finland – joinpoint regression analysis 2023 ·BMC Public Health ·(unknown), Emmi Sarvikivi, Päivi Laukkanen‐Nevala, Otto Helve	6
4	Invasive beta-haemolytic streptococcal infections, Finland, 2006 to 2020: increase in Lancefield group C/G infections 2023 ·Eurosurveillance ·Dafni Katerina Paspaliari, Emmi Sarvikivi, Jukka Ollgren, Jaana Vuopio	6
5	COVID-19 cases in spectators returning to Finland from UEFA Euro 2020 matches in Saint Petersburg 2022 ·Epidemiology and Infection ·Emmi Sarvikivi, Mika Salminen, Carita Savolainen‐Kopra, Niina Ikonen, Mia Kontio, (unknown), (unknown), Tuula Hannila‐Handelberg, Olli Vapalahti, Teemu Smura, Maija Lappalainen, Otto Helve	3
6	Closing lower secondary schools had no impact on COVID-19 incidence in 13–15-year-olds in Finland 2021 ·Epidemiology and Infection ·(unknown), Emmi Sarvikivi, Päivi Laukkanen‐Nevala, Otto Helve	7
7	Three clusters of carbapenemase-producing Citrobacter freundii in Finland, 2016–20 2021 ·Journal of Antimicrobial Chemotherapy ·Kati Räisänen, Emmi Sarvikivi, (unknown), (unknown), (unknown), Eveliina Tarkka, Veli‐Jukka Anttila, Juha O. Grönroos, Esa Rintala, (unknown), (unknown), Markku Broas, Janne Mikkola, (unknown), Jari Jalava, Outi Lyytikäinen	14
8	Multi‐inflammatory syndrome and Kawasaki disease in children during the COVID‐19 pandemic: A nationwide register‐based study and time series analysis 2021 ·Acta Paediatrica ·(unknown), Otto Helve, Emmi Sarvikivi, Merja Helminen, Tea Nieminen, Ville Peltola, Marjo Renko, Harri Saxén, (unknown), Tytti Pokka, (unknown), Terhi Tapiainen	8
9	Three clusters of carbapenemase-producing Citrobacter freundii in Finland, 2016-20 2021 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Kati Räisänen, Emmi Sarvikivi, (unknown), (unknown), (unknown), Eveliina Tarkka, Veli‐Jukka Anttila, Juha O. Grönroos, Esa Rintala, (unknown), (unknown), Markku Broas, Janne Mikkola, (unknown), Jari Jalava, Outi Lyytikäinen	1
10	Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018 2020 ·European Journal of Clinical Microbiology & Infectious Diseases ·Kati Räisänen, Outi Lyytikäinen, (unknown), Eveliina Tarkka, (unknown), Juha O. Grönroos, Risto Vuento, (unknown), Emmi Sarvikivi, (unknown), Jari Jalava	18
11	Surgical site infections following hip and knee arthroplastic surgery: Trends and risk factors of Staphylococcus aureus infections 2018 ·Infection Control and Hospital Epidemiology ·(unknown), Emmi Sarvikivi, Kaisa Huotari, Jukka Ollgren, Outi Lyytikäinen	6
12	Decrease in seroprevalence for herpesviruses among pregnant women in Finland: cross-sectional study of three time points 1992, 2002 and 2012 2015 ·Infectious Diseases ·Laura Puhakka, Emmi Sarvikivi, Maija Lappalainen, Heljä‐Marja Surcel, Harri Saxén	41
13	Multiple norovirus outbreaks linked to imported frozen raspberries 2011 ·Epidemiology and Infection ·Emmi Sarvikivi, Merja Roivainen, Leena Maunula, Taina Niskanen, Tellervo Korhonen, Maija Lappalainen, Markku Kuusi	105
14	Repeated prevalence surveys of healthcare-associated infections in Finnish neonatal intensive care units 2010 ·Journal of Hospital Infection ·Emmi Sarvikivi, Tommi Kärki, Outi Lyytikäinen	17
15	Nosocomial infections after pediatric cardiac surgery 2008 ·American Journal of Infection Control ·Emmi Sarvikivi, Outi Lyytikäinen, Heta Nieminen, Heikki Sairanen, Harri Saxén	39
16	Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland 2008 ·Clinical Microbiology and Infection ·Emmi Sarvikivi, O. Lyytikäinen, Martti Vaara, Harri Saxén	17
17	Healthcare-Associated Infections in Pediatrics 2008 ·STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) ·Emmi Sarvikivi	1
18	Emergence of Fluconazole Resistance in a Candida parapsilosis Strain That Caused Infections in a Neonatal Intensive Care Unit 2005 ·Journal of Clinical Microbiology ·Emmi Sarvikivi, Outi Lyytikäinen, David R. Soll, Claude Pujol, Michael A. Pfaller, Malcolm Richardson, Pirkko Koukila-Kähkölä, Päivi Luukkainen, Harri Saxén	141
19	Clustering of Serratia marcescens Infections in a Neonatal Intensive Care Unit 2004 ·Infection Control and Hospital Epidemiology ·Emmi Sarvikivi, Outi Lyytikäinen, Saara Salmenlinna, Jaana Vuopio‐Varkila, Päivi Luukkainen, (unknown), Harri Saxén	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact